Webinar on Novel COVID-19 & Infectious Diseases will be hosted on July 27, 2021, in London, United Kingdom (GMT+1). Panel of speakers will be delivering their presentations on their recent research related to COVID-19 & Infectious Diseases. Current state of knowledge, its impact on future will be discussed in detailed. Meetings International invites all experts to be part this webinar series and make it a perfect platform for knowledge sharing and networking. Novel COVID-19 will influence an appealing moment to meet people in the experimentation field and therefore it takes a pleasure in opening a doorway to encounter the ability in the field, young researchers and potential World-renowned speakers.
Session 01: Corona Virus (Novel COVID-19)
Coronaviruses are a large family of respiratory viruses, known to cause illness ranging from the common cold to more severe illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The current outbreak has been caused by a strain of coronavirus that had not previously detected anywhere in the world before the outbreak was reported in Wuhan, China in December 2019. COVID-19 is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus strain.
Session 02: Transmission of COVID- 19
Transmission of SARS-CoV-2 can occur through direct, indirect, or close contact with infected people through infected secretions such as saliva and respiratory secretions or their respiratory droplets, which are expelled when an infected person coughs, sneezes, talks or sings. When COVID-19 was clearly becoming a critical threat to many countries around the world, the evidence indicated that the virus spreads from person to person through small respiratory droplets produced when people cough or sneeze, or even breathe. These droplets tend to travel a few feet and then land on surfaces, where the virus could last for up to three days. This is why most of the advice to stop its transmission have centred on lockdowns, physical distancing, handwashing with soap, and the use of alcohol-based hand sanitising gels.
Session 03: Signs & Symptoms of COVID-19
Signs and symptoms include respiratory symptoms and include fever, cough and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome and sometimes death. Standard recommendations to prevent the spread of COVID-19 include frequent cleaning of hands using alcohol-based hand rub or soap and water; covering the nose and mouth with a flexed elbow or disposable tissue when coughing and sneezing; and avoiding close contact with anyone that has a fever and cough.
Session 04: Infection and Immune System
The microbial invasion and their growth inside the host body are known as infection. Certain network of cells, tissues, and organs fight against infection that causes disease is called as immune system. The infection and immunity provide the interaction between bacterial fungal and parasitic pathogen interactions between hosts. This area includes expanded scientific study information on molecular pathogenesis, virulence factors, cellular microbiology, experimental models of infection, host resistance or susceptibility, the generation of innate and adaptive immune responses, innovative techniques that determine the Immunodeficiency disorders, autoimmune disorders, allergic disorders, and immune system studies and thoughts will be shared.
Session 05: Antiviral, Antibacterial, Antimicrobial Agents
An antimicrobial is an agent that kills or inhibits the boom of microorganisms. The microbial agent can be chemical substances and bodily retailers. Those sellers interfere with the increase and duplicate of causative organisms like bacteria, fungi, parasites, and virus and so on. The magazine of Antimicrobial sellers shares up statistics approximately antibacterial, antifungal, antiviral, anti-protozoa, anti-algal retailers and their strategies of detection, unique treatment plans and advanced remedies to prevent and control the infectious diseases.
Market Analysis:
Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control. Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.
Infectious Diseases Analysis in Europe:
Europe Infectious Disease Diagnostics Market By Product & Service (Assays, Kits, Reagents, Instruments, Service & Software), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies), Disease Type (Hepatitis, HIV, CT/NG, HAIS, HPV, TB, Influenza, Other Infectious Diseases), End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users), Country (Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2026
Europe infectious disease diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to the surging demand for new diagnostic tests for the control of infectious diseases is contributing to market growth.
Members associated with Infectious Diseases
Worldwide Data
Societies and Associations related to Infectious Diseases
Universities related to Infectious Diseases
References